BioSpace News Archive

Advanced ICU Care, the nation’s leading provider of high-acuity telemedicine, announced a tele-ICU services launch with HSHS St. Mary’s Hospital, a full-service health care facility serving central Illinois.

Report entitled “Treating Investors ALMOST Like Family” outlines how LHC Group, Inc. faces 35%-65% downside risk to approximately $60-$90 per share.

The third proton therapy center launched by Provision Healthcare is currently under construction in Southwest Orange County, Florida.

Global safe-surgery non-profit Lifebox and health system innovation center Ariadne Labs announce the release of the “Checking in on the Checklist” report.

The Board of Directors of myFace is pleased to announce the appointment of Stephanie Paul as the new executive director of the organization, taking the helm of one of the country’s leading nonprofits dedicated to helping those with craniofacial differences receive the best possible care.

Supply Chain Issues, the Need for Additional Talent Chemists, Lower Drug Prices, Growth of Development in the U.S. Will Be Key Factors.

This analysis investigates CLI patients, who despite a successful procedure, do not respond to endovascular and surgical revascularization.

With the potential to cause up to 90 percent annual yield loss, nematodes can be a key threat to a potato crop.

SparingVision, a biotechnology company innovating treatment of blinding inherited retinal diseases such as Retinitis Pigmentosa and pioneer in the development of a gene-independent treatment for retinitis pigmentosa, attends the Biotech Showcase in San Francisco to meet with investors and strategic partners.

First stage clinical efficacy endpoint met for the Phase II trial cohort evaluating selective AXL inhibitor bemcentinib in combination with Keytruda® in patients with advanced NSCLC who have failed checkpoint inhibitor therapy